Đặc điểm tràn dịch màng phổi cận viêm phổi và tràn mủ màng phổi ở trẻ em tại Bệnh viện Nhi Đồng 1

To describe epidemiological features, clinical manifestations, laboratory investigation and treatments of parapneumonic effusion and empyema. Design: Descriptive study. Result: From January 2017 to August 2022, we studied 134 parapneumonic effusion and empyema patients in children at Children’s Hospital 1. Age range mostly under 5 year-old, male/female 1.6/1. Disease occurs mostly in October, November, December and January. 64/134 need intervention with pleural drainage or surgery, have longer day of symptoms before hospitalisation, higher rate of reference from other hospitals, repiratory failure, anemia, CRP>50mg/dL and more complicated characteristics of pleural ultrasound. Causal agent areS.aureus 52.5% and S.pneumoniae 42.5%. MRSA occupies 90% of S.aureus, 100% sensitive with vancomycin. Resistance rate of S.pneumoniae is 40% with PNC or Cephalosporin 3rd. Treatment with antibiotics which covers these 2 agents is 90%. Success rate of pleural drainage is 38.8%. Rate of surgery 44.7% with VATS>80%. No death recorded. Conclusion: Parapneumonic effusion and empyema occurs mostly in male, under 5 year-old. Factors that may relate to intervention include longer days of symptoms before hospitalisation, respiratory failure, reference from other hospitals, CRP>50mg/dL and complicated features on ultrasound. Causal agents mostly are S.aureus and S.pneumoniae. Most of intervention cases is surgery.